Elevance Health Inc.

ELV | NYSE

Price Alert Chart Builder DCF Calculator

$397.18

-$1.38 (-0.35%)

Sep 24, 2026, 11:15 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	50.47B	50.18B	49.75B	50.71B	49.78B	48.89B	45.44B	45.15B	43.65B	42.58B	42.65B	42.85B	43.67B	42.17B	39.93B	39.94B	38.63B	38.1B	36.58B	35.82B	33.85B	32.39B
Cost of Revenue	5.49B	41.08B	38.07B	38.14B	36.71B	35.31B	33.5B	32.95B	30.57B	30.55B	31.33B	30.61B	31.6B	30.79B	30.2B	29.42B	28.8B	28.23B	27.54B	26.65B	24.76B	23.7B
Gross Profit	44.98B	9.1B	11.68B	12.57B	13.07B	13.58B	11.94B	12.2B	13.07B	12.03B	11.31B	12.24B	12.07B	11.39B	9.73B	10.52B	9.84B	9.86B	9.04B	9.18B	9.09B	8.69B
Operating Income	2.06B	2.66B	581M	1.76B	2.63B	3.14B	946M	1.71B	3.03B	3.2B	1.26B	1.91B	2.7B	2.87B	1.27B	2.34B	2.33B	2.51B	1.59B	2.2B	2.56B	2.37B
Interest Income	704M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	1.94B	2.3B	215M	1.41B	2.29B	2.8B	606M	1.37B	2.99B	2.94B	1B	1.65B	2.44B	2.62B	1.05B	2.13B	2.12B	2.31B	1.4B	2B	2.35B	2.18B
Net Income	1.46B	1.76B	547M	1.19B	1.74B	2.18B	418M	1.02B	2.3B	2.25B	856M	1.29B	1.85B	1.99B	865M	1.6B	1.64B	1.79B	1.14B	1.51B	1.79B	1.67B
Selling & General & Admin	n/a	6.33B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	42.92B	112M	11.1B	10.81B	10.44B	10.44B	11B	10.48B	10.05B	8.83B	10.05B	10.33B	9.37B	8.52B	8.46B	8.18B	7.51B	7.36B	7.45B	6.98B	6.53B	6.32B
Operating Expenses	42.92B	6.44B	11.1B	10.81B	10.44B	10.44B	11B	10.48B	10.05B	8.83B	10.05B	10.33B	9.37B	8.52B	8.46B	8.18B	7.51B	7.36B	7.45B	6.98B	6.53B	6.32B
Interest Expense	56M	357M	366M	351M	341M	344M	340M	300M	280M	265M	259M	259M	261M	251M	229M	213M	208M	201M	200M	201M	205M	192M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	48.41B	47.52B	49.17B	48.95B	47.14B	45.75B	44.5B	43.43B	40.62B	39.37B	41.39B	40.94B	40.97B	39.3B	38.66B	37.6B	36.3B	35.59B	34.99B	33.63B	31.29B	30.02B
Income Tax Expense	483M	544M	-331M	219M	548M	613M	193M	365M	685M	690M	170M	354M	585M	615M	168M	529M	488M	527M	275M	494M	552M	509M
Shares Outstanding (Basic)	217.9M	220.4M	221.8M	225.8M	225.8M	226.4M	227.48M	233.03M	232.2M	232.7M	233.07M	235.3M	236.6M	237.5M	237.96M	239.6M	240.7M	241.4M	241.77M	243.4M	244.5M	245M
Shares Outstanding (Diluted)	217.9M	220.4M	221.8M	225.8M	225.8M	227.2M	231.1M	233.1M	233.4M	234.2M	235.8M	236.5M	237.8M	239.7M	241.2M	242.2M	243.4M	244.4M	245.5M	246M	247.4M	248.2M
EPS (Basic)	6.71	8	2.47	5.32	7.72	9.64	1.84	4.36	9.91	9.65	3.67	5.48	7.83	8.37	3.64	6.69	6.80	7.41	4.70	6.20	7.33	6.80
EPS (Diluted)	6.71	8	2.47	5.32	7.72	9.61	1.81	4.36	9.85	9.59	3.63	5.45	7.79	8.30	3.59	6.62	6.73	7.32	4.63	6.13	7.25	6.71
EBITDA	2.1B	2.77B	987M	2.14B	3.01B	3.51B	1.34B	2B	3.6B	3.54B	1.68B	2.34B	3.14B	3.33B	1.75B	2.79B	2.72B	2.87B	1.96B	2.55B	2.87B	2.65B
EBIT	1.99B	2.66B	581M	1.76B	2.63B	3.14B	946M	1.67B	3.27B	3.2B	1.26B	1.91B	2.7B	2.87B	1.27B	2.34B	2.33B	2.51B	1.6B	2.2B	2.56B	2.37B
Depreciation & Amortization	110M	112M	406M	387M	380M	373M	398M	329M	335M	331M	424M	426M	433M	462M	473M	451M	393M	358M	360M	351M	309M	282M